Table 3:
HNSCC (n=318) | |||
---|---|---|---|
ERα Staining Cutoffs | n | HR (95% CI) | aHR (95%CI)* |
Percentage Positivity | |||
≥1% | 115 | 0.39 (0.18–0.85) | 0.81 (0.26–2.51) |
≥10% | 105 | 0.47 (0.22–1.0) | 1.1 (0.37–3.54) |
≥20% | 77 | 0.33 (0.12–0.93) | 0.53 (0.11–2.50) |
≥35% | 52 | 0.40 (0.12–1.30) | 0.59 (0.07–4.90) |
Staining Intensity | |||
1–3 | 115 | 0.39 (0.18–0.85) | 0.81 (0.26–2.51) |
2–3 | 92 | 0.40 (0.17–0.95) | 0.77 (0.24–2.54) |
3 | 47 | 0.55 (0.19–1.53) | 1.07 (0.30–3.82) |
Adjusted for age, HPV tumor status and smoking
Abbreviations: HNSCC, head and neck squamous cell cancer; HR, hazard ratio; CI, confidence interval; Ref, reference group.
Bolding indicates statistical significance.